InvestorsHub Logo
Followers 13
Posts 306
Boards Moderated 0
Alias Born 03/02/2020

Re: J-Belfort post# 109624

Sunday, 08/23/2020 9:24:47 AM

Sunday, August 23, 2020 9:24:47 AM

Post# of 232209
True.

CYDY competitor HAS BEEN doing a placebo controlled trial, the results of which are just not public



HGEN P3 trials for lenzilumab have been going on long enough that they must be near time for reporting interim results. Enrollment began approx May 1. If they enroll 10/week (which is about the rate CYDY has been enrolling in s/c and m/m trials, albeit with a lot of variation), they would be at about 150 now, which would put them a little too early for interim results because trial treatment period is 28 days. Unless they have been enrolling at 15/week (completely not impossible), I wouldn't expect to hear anything from them for a month or so. However, they did announce on an August 3 conference call [19:10] that interim data would be discussed in the near future. Possibly they have submitted them to FDA or DMSB has reported without announcing anything to the public?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News